Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali

International Journal for Parasitology

Volumn 40, Issue 10, 2010, Pages 1213-1220

  Beavogui, Abdoul H ^a,c   Djimde, Abdoulaye A ^a   Gregson, Aric ^b   Toure, Abdoulaye M ^a   Dao, Adama ^a   Coulibaly, Boubacar ^a   Ouologuem, Dinkorma ^a   Fofana, Bakary ^a   Sacko, Adama ^a   Tekete, Mamadou ^a   Kone, Aminatou ^a   Niare, Oumou ^a   Wele, Mamadou ^a   Plowe, Christopher V ^b   Picot, Stephane ^c   Doumbo, Ogobara K ^a  

^a UNIVERSITY OF BAMAKO   (Mali)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Anopheles gambiae; Gametocytes; Infectivity; Mali; Plasmodium falciparum; Sulfadoxine pyrimethamine

Indexed keywords

CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

DISEASE TRANSMISSION; DRUG RESISTANCE; ENZYME; MALARIA; MUTATION; PARASITE; PARASITE PREVALENCE;

ADOLESCENT; ADULT; ANOPHELES GAMBIAE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GAMETOCYTE; GENE MUTATION; GENOTYPE; HUMAN; INFANT; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MALI; NONHUMAN; OOCYST; PARASITE TRANSMISSION; PARASITE VIRULENCE; PARASITEMIA; PLASMODIUM FALCIPARUM; SINGLE DRUG DOSE; TROPHOZOITE;

ANIMALS; ANOPHELES GAMBIAE; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALARIA, FALCIPARUM; MALI; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

MALI;

ANOPHELES GAMBIAE; PLASMODIUM FALCIPARUM;

EID: 77954028849     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.04.010     Document Type: Article

References (60)

1. Alano P., Roca L., Smith D., Read D., Carter R., Day K. Plasmodium falciparum: parasites defective in early stages of gametocytogenesis. Exp. Parasitol. 1995, 81:227-235.
2. Anonymous, 1973. Chemotherapy of Malaria and Resistance to Antimalarials. World Health Organization, Geneva. WHO Technical Report Series, No. 529.
3. Anonymous, 2003. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated falciparum Malaria. Geneva, WHO/HTM/RBM/2003.50.
4. Barnes K.I., Little F., Mabuza A., Mngomezulu N., Govere J., Durrheim D., Roper C., Watkins B., White N.J. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. Infect. Dis. 2008, 197:1605-1613.
5. Bharti A.R., Chuquiyauri R., Brouwer K.C., Stancil J., Lin J., Llanos-Cuentas A., Vinetz J.M. Experimental infection of the neotropical malaria vector anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon. Am. J. Trop. Med. Hyg. 2006, 75:610-616.
6. Bonnet S., Gouagna C., Safeukui I., Meunier J., Boudin C. Comparison of artificial membrane feeding with direct skin feeding to estimate infectiousness of Plasmodium falciparum gametocyte carriers to mosquitoes. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:103-106.
7. Buckling A., Read A.F. The effect of partial host immunity on the transmission of malaria parasites. Proc. R. Soc. Lond. B Biol. Sci. 2001, 268:2325-2330.
8. Butcher G.A. Antimalarial drugs and the mosquito transmission of Plasmodium. Int. J. Parasitol. 1997, 27:975-987.
9. Carter R., Miller L.H. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull. World Health Organ. 1979, 57(Suppl. 1):37-52.
10. Chotivanich K., Sattabongkot J., Udomsangpetch R., Looareesuwan S., Day N.P., Coleman R.E., White N.J. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob. Agents Chemother. 2006, 50:1927-1930.
11. Chutmongkonkul M., Maier W.A., Seitz H.M. Plasmodium falciparum: effect of chloroquine, halofantrine and pyrimethamine on the infectivity of gametocytes for Anopheles stephensi mosquitoes. Ann. Trop. Med. Parasitol. 1992, 86:103-110.
12. Clarke S.E., Jukes M.C.H., Kiambo Njagi H., Khasakhala L., Cundill B., Otido J., Crudder C., Estambale B.B., Brooker S. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomized, double-blind, placebo-controlled trial. Lancet 2008, 372:127-138.
13. Day K.P., Karamalis F., Thompson J., Barnes D.A., Peterson C., Brown H., Brown G.V., Kemp D.J. Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-megabase region of chromosome 9. Proc. Natl. Acad. Sci. USA 1993, 90:8292-8296.
14. Diourte Y., Djimde A., Doumbo O.K., Sagara I., Coulibaly Y., Dicko A., Diallo M., Diakite M., Cortese J.F., Plowe C.V. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. Am. J. Trop. Med. Hyg. 1999, 60:475-478.
15. Djimde A., Doumbo O.K., Traore O., Guindo A., Kayentao K., Diourte Y., Doumbo S.N., Coulibaly D., Kone A., Cissoko Y., Tekete M., Fofana B., Dicko A., Diallo D.A., Wellems T.E., Kwiatkowski D., Plowe C.V. Clearance of drug-resistant parasites as a model for protective immunity in falciparum malaria. Am. J. Trop. Med. Hyg. 2003, 69:558-563.
16. Dorsey G., Dokomajilar C., Kiggundu M., Staedke S.G., Kamya M.R., Rosenthal P.J. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. Am. J. Trop. Med. Hyg. 2004, 71:758-763.
17. Doumbo O.K., Kayentao K., Djimde A., Cortese J.F., Diourte Y., Konaré A., Kublin J.G., Plowe C.V. Rapid selection of P. falciparum DHFR mutants by pyrimethamine prophylaxis. J. Infect. Dis. 2000, 182:993-996.
18. Drakeley C.J., Secka I., Correa S., Greenwood B.M., Targett G.A. Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes. Trop. Med. Int. Health 1999, 4:131-138.
19. Drakeley C.J., Bousema J.T., Akim N.I., Teelen K., Roeffen W., Lensen A.H., Bolmer M., Eling W., Sauerwein R.W. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers. Parasite Immunol. 2006, 28:185-190.
20. Dyer M., Day K.P. Commitment to gametocytogenesis in Plasmodium falciparum. Parasitol. Today 2000, 16:102-107.
21. Enosse S., Butcher G.A., Margos G., Mendoza J., Sinden R.E., Hogh B. The mosquito transmission of malaria: the effects of atovaquone-proguanil (malarone) and chloroquine. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:77-82.
22. Govere J.M., Durrheim D.N., Mngomezulu N.M., Barnes K., Sharp B. Infectivity of Plasmodium falciparum gametocytes to Anopheles arabiensis after treatment with sulfadoxine-pyrimethamine. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:707-708.
23. Graves P.M., Burkot T.R., Carter R., Cattani J.A., Lagog M., Parker J., Brabin B.J., Gibson F.D., Bradley D.J., Alpers M.P. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology 1988, 96:251-263.
24. Hallett R.L., Dunyo S., Ord R., Jawara M., Pinder M., Randall A., Alloueche A., Walraven G., Targett G.A., Alexander N., Sutherland C.J. Chloroquine/sulphadoxine-pyrimethamine for Gambian children with malaria: Transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin. Trials 2006, 1:e15.
25. Hogh B., Thompson R., Hetzel C., Fleck S.L., Kruse N.A., Jones I., Dgedge M., Barreto J., Sinden R.E. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of mozambique. Am. J. Trop. Med. Hyg. 1995, 52:50-59.
26. Hogh B., Gamage-Mendis A., Butcher G.A., Thompson R., Begtrup K., Mendis C., Enosse S.M., Dgedge M., Barreto J., Eling W., Sinden R.E. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am. J. Trop. Med. Hyg. 1998, 58:176-182.
27. Jeffery G.M. Infectivity to mosquitoes of Plasmodium vivax following treatment with chloroquine and other antimalarials. Am. J. Trop. Med. Hyg. 1963, 4:207-211.
28. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 2002, 185:380-388.
29. Ladeia-Andrade S., Ferreira M.U., de Carvalho M.E., Curado I., Coura J.R. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. Am. J. Trop. Med. Hyg. 2009, 80:452-459.
30. Lines J.D., Wilkes T.J., Lyimo E.O. Human malaria infectiousness measured by age-specific sporozoite rates in Anopheles gambiae in tanzania. Parasitology 1991, 102(Pt. 2):167-177.
31. Mendez F., Munoz A., Carrasquilla G., Jurado D., Arevalo-Herrera M., Cortese J.F., Plowe C.V. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am. J. Epidemiol. 2002, 156:230-238.
32. Méndez F., Herrera S., Murrain B., Gutiérrez A., Moreno L.A., Manzano M., Muñoz A., Plowe C.V. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. Am. J. Trop. Med. Hyg. 2007, 77:438-443.
33. Newman R.D., Moran A.C., Kayentao K., et al. Prevention of malaria during pregnancy in West Africa: policy change and the power of subregional action. Trop. Med. Int. Health 2006, 11:462-469.
34. Nosten F., van Vugt M., Price R., Luxemburger C., Thway K.L., Brockman A., McGready R., ter Kuile F., Looareesuwan S., White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western thailand: a prospective study. Lancet 2000, 356:297-302.
35. Oesterholt M.J., Alifrangis M., Sutherland C.J., Omar S.A., Sawa P., Howitt C., Gouagna L.C., Sauerwein R.W., Bousema T. Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya. PLoS One 2009, 4(2):e4364.
36. O'Meara W.P., Smith D.L., McKenzie F.E. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 2006, 5:e141.
37. Peterson D.S., Milhous W.K., Wellems T.E. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 1990, 87:3018-3022.
38. Plowe C.V., Djimde A., Bouare M., Doumbo O., Wellems T.E. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 1995, 52:565-568.
39. Plowe C.V., Djimde A., Wellems T.E., Diop S., Kouriba B., Doumbo O.K. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am. J. Trop. Med. Hyg. 1996, 55:467-471.
40. Plowe Christopher V., Doumbo Ogobara K., Djimde Abdoulaye, Kayentao Kassoum, Diourte Yacouba, Doumbo Safi N., Coulibaly Drissa, Thera Mahamadou, Wellems Thomas E., Diallo Dapa A. Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitological resistance vs. therapeutic efficacy. Am. J. Trop. Med. Hyg. 2001, 64:242-246.
41. Price R., Nosten F., Luxemburger C., ter K.F., Paiphun L., Chongsuphajaisiddhi T., White N. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996, 347:1654-1658.
42. Robert V., Read A.F., Essong J., Tchuinkam T., Mulder B., Verhave J.P., Carnevale P. Effect of gametocyte sex ratio on infectivity of Plasmodium falciparum to Anopheles gambiae. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:621-624.
43. Robert V., Awono-Ambene H.P., Le Hesran J.Y., Trape J.F. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am. J. Trop. Med. Hyg. 2000, 62:210-216.
44. Schneider P., Bousema T., Omar S., Gouagna L., Sawa P., Schallig H., Sauerwein R. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int. J. Parasitol. 2006, 36:403-408.
45. Schneider P., Bousema T., Omar S., Gouagna L., Sawa P., Schallig H., Sauerwein R. (Sub) microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int. J. Parasitol. 2006, 36:403-408.
46. Shute P.G., Maryon M. The effect of pyrimethamine (daraprim) on the gametocytes and oocysts of Plasmodium falciparum and Plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg. 1954, 48:50-63.
47. Smalley M.E. Plasmodium falciparum gametocytes: the effect of chloroquine on their development. Trans. R. Soc. Trop. Med. Hyg. 1977, 71:526-529.
48. Smalley M.E., Sinden R.E. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 1977, 74:1-8.
49. Smalley M.E., Brown J., Bassett N.M. The rate of production of Plasmodium falciparum gametocytes during natural infections. Trans. R. Soc. Trop. Med. Hyg. 1981, 75:318-319.
50. Sokhna C.S., Trape J.F., Robert V. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine+pyrimethamine. Parasite 2001, 8:243-250.
51. Sowunmi A., Fateye B.A. Plasmodium falciparum gametocytemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop. Med. Int. Health 2003, 8:783-792.
52. Strickland G.T., Fox E., Sarwar M., Khaliq A.A., Macdonald M. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia. Am. J. Trop. Med. Hyg. 1986, 35:259-262.
53. Targett G., Drakeley C., Jawara M., von Seidlein L., Coleman R., Deen J., Pinder M., Doherty T., Sutherland C., Walraven G., Milligan P. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 2001, 183:1254-1259.
54. Tekete M., Djimde A.A., Beavogui A.H., Maiga H., Sagara I., Fofana B., Ouologuem D., Dama S., Kone A., Dembele D., Wele M., Dicko A., Doumbo O.K. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging amodiaquine and SP resistance in Mali. Malar. J. 2009, 26:34.
55. ter Kuile F.O., Steketee R.W. Intermittent preventive treatment in infants-adjusting expectations and seeing opportunity. J. Infect. Dis. 2006, 194:269-272.
56. Thera M.A., Sehdev P.S., Coulibaly D., Traore K., Garba M.N., Cissoko Y., Kone A., Guindo A., Dicko A., Beavogui A.H., Djimde A.A., Lyke K.E., Diallo D.A., Doumbo O.K., Plowe C.V. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J. Infect. Dis. 2005, 5(192):1823-1829.
57. Toure Y.T., Doumbo O., Toure A., Bagayoko M., Diallo M., Dolo A., Vernick K.D., Keister D.B., Muratova O., Kaslow D.C. Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine site. Am. J. Trop. Med. Hyg. 1998, 59:481-486.
58. Triglia T., Menting J.G.T., Wilson C., Cowman A.F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 1997, 94:13944-13949.
59. von Seidlein L., Jawara M., Coleman R., Doherty T., Walraven G., Targett G. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop. Med. Int. Health 2001, 6:92-98.
60. Zolg J.W., Plitt J.R., Chen G.X., Palmer S. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 1989, 36:253-262.